Clinical Trial Update: High-activity Natural Killer Immunotherapy for Small Metastases of Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update of high-activity natural killer cell immunotherapy for small metastases in pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED